I think many might agree here, as Intellectual Property is getting pretty gray these days.  Software companies seem to have a better handle on this, but they even face challenges too.  Once you share intellectual property, the cat's out of the bag per se.  Add on some economic constraints and profitability studies and things get very gray. 

Biotech technology though is software development, as that is what allows progress, so perhaps it might come back around to ethics some day, that is if there are any left out there.  I make that comment just relative to the information I post every day on this blog.  BD  image

NEW YORK (GenomeWeb News) - The worlds intellectual property system is broken, stifling innovation and stopping life-saving technologies from reaching the people who need them most in developed and developing countries, according to a report released this week by an international coalition of experts. The report, entitled Toward a New Era of Intellectual Property: From Confrontation to Negotiation, was funded by the Social Sciences and Humanities Research Council of Canada, and is the result of seven years of work by McGill University professor Richard Gold and a group of experts in law, ethics, and economics called the International Expert Group on Biotechnology, Innovation, and IP.

Instead, the authors assert that biotech players need to adopt a “new IP” strategy that focuses on cooperation and collaboration at all levels; and make several recommendations to government, industry, and university officials to help implement such a strategy.

GenomeWeb News: Report: Current IP System Stifles Biotech Innovation, Impedes Rx Access in Developing World

0 comments :

Post a Comment

 
Top
Google Analytics Alternative